Journal
BIOINTERPHASES
Volume 16, Issue 1, Pages -Publisher
AMER INST PHYSICS
DOI: 10.1116/6.0000755
Keywords
-
Categories
Funding
- Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD081123-01A1]
- Vincent Coates Foundation Mass Spectrometry Laboratory
Ask authors/readers for more resources
The study aimed to investigate whether patients with or without hypersensitivity reactions to ferumoxytol nanoparticles develop specific protein corona profiles. The results suggest that analyzing the biomolecular corona ex vivo may provide predictive information on severe allergic reactions to ferumoxytol nanoparticles, potentially allowing for the diagnosis of patients predisposed to an allergic reaction based on proteomic patterns in the corona.
Ferumoxytol nanoparticles are being used clinically for the treatment of anemia and molecular imaging in patients. It is well documented that while most patients tolerate ferumoxytol well, a small percentage of patients (i.e., 0.01%) develop severe allergic reactions. The purpose of our proof-of-concept study was to determine whether patients with or without hypersensitivity reactions have specific protein corona profiles around ferumoxytol nanoparticles. In a retrospective, institutional review board approved pilot study, we enrolled 13 pediatric patients (5 girls, 8 boys, mean age 16.9 +/- 8.2 years) who received a ferumoxytol-enhanced magnetic resonance imaging and who did (group 1, n = 5) or did not (group 2, n = 8) develop an allergic reaction. Blood samples of these patients were incubated with ferumoxytol, and the formation of a hard protein corona around ferumoxytol nanoparticles was measured by dynamic light scattering, zeta potential, and liquid chromatography-mass spectrometry. We also performed in vitro immune response analyses to randomly selected coronas from each group. Our results provide preliminary evidence that ex vivo analysis of the biomolecular corona may provide useful and predictive information on the possibility of severe allergic reactions to ferumoxytol nanoparticles. In the future, patients with predisposition of an allergic reaction to ferumoxytol may be diagnosed based on the proteomic patterns of the corona around ferumoxytol in their blood sample.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available